Event Description:
Through multidisciplinary presentations from HPB cancer experts in medical oncology, surgical oncology, gastroenterology, and interventional radiology, the latest data on treatment of HPB malignancies will be discussed and highlighted with clinical case presentations and audience participation.
Objectives
Implement new systemic therapies for ICC and HCC.
Describe the role of neoadjuvant therapy for PDAC.
Employ updated treatment and management of CLM including HAI+ systemic treatment, liver directed therapy, surgery, transplant in selected cases.
Review and discuss systemic therapy including PRRT in PNET.
Discuss outcomes of Whipple surgery vascular resection and reconstruction.
Discuss access to complex oncologic treatment for underserved populations.
Discuss liver directed therapy for locally advanced intrahepatic cholangiocarcinoma.
Discuss latest research on less invasive treatment options for colorectal liver metastases.
Available Credits
Audience
This activity is designed for surgeons, medical oncologists, gastroenterologists, radiation oncologists, nurses, physician assistants and nurse practitioners.